TITLE

SSRI treatment for under-18s

AUTHOR(S)
Bhandari, Mohit; Montori, Victor M.; Devereaux, P. J.
PUB. DATE
June 2004
SOURCE
CMAJ: Canadian Medical Association Journal;6/8/2004, Vol. 170 Issue 12, p1771
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents the response of Mohit Bhandari, Victor M. Montori and P. J. Devereaux to a letter to the editor about their article on industry bias in reporting drug trials.
ACCESSION #
13258260

 

Related Articles

  • Medical benefits. Iliffe, Steve // British Journal of General Practice;Nov2005, Vol. 55 Issue 520, p886 

    A letter to the editor is presented in response to the article "When the Drugs Don't Work," by Alec Logan in a 2005 issue.

  • Trial of Modafinil for Cocaine Dependence. Umanoff, Dan F. // Neuropsychopharmacology;Dec2005, Vol. 30 Issue 12, p2298 

    Presents a letter to the editor regarding a study on the use of modafinil as treatment for cocaine dependence.

  • SSRI treatment for under-18s. Voysey, Mark A. // CMAJ: Canadian Medical Association Journal;6/8/2004, Vol. 170 Issue 12, p1771 

    Presents a letter to the editor in response to an article about industry bias in reporting drug trial results which appeared in the "Canadian Medical Association Journal."

  • Authentication and voucher number for crude plant drugs. Mujumdar, A. M.; Upadhye, Anuradha S. // Current Science (00113891);4/10/2007, Vol. 92 Issue 7, p875 

    A letter to the editor about authentication and voucher deposition of crude herbal drug samples is presented.

  • TRIAL OF PIRACETAM' IN CHRONIC SCHIZOPHRENIA. Pryce, I. G.; Gray, Charles // British Journal of Psychiatry;Feb78, Vol. 132, p205 

    A letter to the editor is presented in response to an article about a double-blind cross-over trial of the drug Piracetam in chronic schizophrenia.

  • Time for a quality check before recruiting patients. Holtedahl, Knut A.; Meland, Eivind // BMJ: British Medical Journal (International Edition);7/7/2007, Vol. 335 Issue 7609, p7 

    A letter to the editor is presented discussing quality control in recruiting patients for drug trials.

  • Pharmaceutical Testing: Company View: The Way It Really Is. Gilgore, Sheldon G. // Bulletin of the Atomic Scientists;Jun1969, Vol. 25 Issue 6, p12 

    A letter to the editor is presented in response to the article "Drug Testing: IS Time Running Out?," by William O'Brien in the January 1969 issue.

  • Pharmaceutical Testing: Critic's View: The Way It Really Is. O'Brien, William M. // Bulletin of the Atomic Scientists;Jun1969, Vol. 25 Issue 6, p13 

    A response by William M. O'Brien to a letter to the editor about his article "Drug Testing: Is Time Running Out?" in the January 1969 issue is presented.

  • A Further Comment. Gilgore, Sheldon G. // Bulletin of the Atomic Scientists;Jun1969, Vol. 25 Issue 6, p16 

    A response by Sheldon G. Gilgore to a comment about his article on drug testing in the June 1, 1969 issue is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics